Medical Chronicle November/December 2013 | Page 31

PAIN Chronic headaches: Current insights Most people have headaches from time to time. When a patient has a headache more days than not, this is known as chronic daily headaches. These are among the most disabling headaches. Aggressive initial treatment and long-term management can reduce pain and lead to fewer chronic daily headaches. By definition, chronic daily headaches must occur 15 days or more a month, for at least three months. To be considered true (primary) chronic daily headaches; they must also not be the result of another condition. The most common primary headache disorders are tension-type headache, and migraine and cluster headache. There are, however, many less commonly occurring primary headache disorders. Despite a much bigger focus on headache disorders, there is still a major educational task regarding both the etiology and treatment of headache for both the patients and the treating health professionals. There is a significant risk for progression from episodic to chronic daily headache, which makes the appropriate treatment of headache early on very important. At the same time, the inappropriate overuse of analgesic medication carries the risk of causing medication-overuse headache (MOH). This has developed into the third most common type of headache after tension-type headache and migraine. This currently affects approximately 1% of the world’s population and is increasing. The pathophysiology of MOH is still unknown. The overuse of any kind of acute headache medication is the main risk factor leading to the development of chronic headache. CHRONIC DAILY HEADACHE Classification and diagnostic criteria Chronic daily headaches are classi- DR ERIC HODGSON Neurologist in private practice, Life Wilgers Hospital and PainSA President fied by how long they last - more than four hours or less than four hours. The longer-lasting headaches are more common and will be discussed here. They’re divided into four types: • Chronic migraine • Chronic tension-type headache • New daily persistent headache • Hemicrania continua. CHRONIC MIGRAINE These headaches evolve from episodic migraine without aura. This is a very important category, since new treatment options have become available for this condition. To be diagnosed with chronic migraine, headaches - migraine, tensiontype or both - must be present 15 days or more a month, for at least three months. In addition, on eight or more days a month for at least three months, headaches with at least two of the following charac- teristics must be present: • Affect only one side of the head • Cause a pulsating, throbbing sensations • Cause moderate to severe pain • Are aggravated by routine physical activity. And they cause at least one of the following: • Nausea, vomiting or both • Sensitivity to light and sound. Response to triptan medication can also be helpful in making this diagnosis. Chronic migraine (CM) is a complex, progressive headache disorder affecting approximately 1%-2% of the general adult population. Patients with CM are less likely to attend social functions and perform household work, and one in five CM sufferers are occupationally disabled, thereby affecting their ability to lead productive lives. omebacks. Great c much better Always their return. on 12 to CAPSULES There’s something magical about a great comeback story. Schumacher, Trump, Elvis. Despite the challenges and negativity, they returned with a ?ghting spirit; more determined than ever before. And now, Synaleve® adds its name to the list. Humbled and apologetic, this analgesic will prove that it is undeniably much better and more prepared than ever before. Trust us to cut the long story of pain short. three to four times per day S5 SYNALEVE® CAPSULES. Eac h capsule contains: Meprobamate 200 mg; codeine phosphate 8 mg; paracetamol 400 mg. No. Reg. B/2.8/80. For full prescribing information refer to the package insert approved by the medicines regulatory authority. ZA.13.PAI.154 07/2013 Adcock Ingram Limited. Reg. No. 1949/034385/06. Private Bag X69, Bryanston, 2021. Tel. +27 11 635 0000. www.adcock.com 1574 Synaleve Journal 1/2 ad -Medical Chronical.indd 1 2013/11/05 8:14 AM MEDICAL CHRONICLE NOVEMBER/DECEMBER 2013 31